HT
HAE icon

Headlands Technologies’s Haemonetics HAE Stock Holding History

Headlands Technologies’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,338
Closed -$114K – 1321
2024
Q1 		$114K Buy
+1,338
New +$105K 0.03% 512

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Headlands Technologies's HAE Position: Q2 2024 in Review

Headlands Technologies sold out of Haemonetics (HAE) in Q2 2024, closing a stake of 1,338 shares — an estimated $114K sold.

Headlands Technologies first reported a position in HAE in Q1 2024 and held it in 1 quarter. The position peaked at $114K in Q1 2024. 317 funds tracked by Wall St. Rank hold HAE as of Q2 2024.

  • Headlands Technologies reported no remaining Haemonetics position as of Q2 2024 after selling out during the quarter.
  • Headlands Technologies sold 1,338 Haemonetics shares in Q2 2024, an estimated $114K.
  • Headlands Technologies first reported a position in Haemonetics in Q1 2024 and held it in 1 quarter.
  • Headlands Technologies's Haemonetics position peaked at $114K in Q1 2024.
  • 317 funds tracked by Wall St. Rank held Haemonetics as of Q2 2024.

Based on Headlands Technologies's 13F filing for Q2 2024, filed 7 Aug 2024.